Natural Killer Cells in Cancer Immunotherapy

NKG2D_ULBP6_Complex
Share

T cells of the adaptive immune system are not the only cytotoxic cells in the immune system. Natural killer cells (NK cells) are a cytotoxic white blood cell (lymphocyte) of the innate immune system. Clinical trials with NK cells use these as cell-based biologic therapies: The NK cells are the therapy. New research suggests that … Read moreNatural Killer Cells in Cancer Immunotherapy

Share

Immune Checkpoint Inhibitor Super Responders

Vaccine_needle
Share

Efforts are underway to identify the molecular reasons why some patients exhibit an enduring response to immune checkpoint inhibitor therapy. These patients have been called “exceptional” responders or “super” responders. Some patients that have cancers with a lot of DNA mutations (high mutational burden) are better responders to immune checkpoint therapy compared with patients that … Read moreImmune Checkpoint Inhibitor Super Responders

Share

Understanding Immune Checkpoint Pathways to Improve Patient Response

Cells_of_the_immune_system
Share

Better understanding of the molecular mechanisms that control the adaptive immune system will lead to better immunotherapies for cancer patients or patients with other diseases related to inappropriate immune responses. Two of the processes that inhibit T cell function are called immune checkpoint pathways. New research reveals that these pathways involve many cells of the … Read moreUnderstanding Immune Checkpoint Pathways to Improve Patient Response

Share